RPTX
|Repare Therapeutics Inc
NASDAQ
USD 1.44
+0.07|+5.11%
Current Price
USD 1.44
Change
+USD 0.07 (5.11%)
P/E Ratio
Dividend Yield
Market Cap
58.33M
Volume
91,824
Open
USD 1.38
Previous Close
USD 1.37
52-Week High
USD 4.29
52-Week Low
USD 0.89
About Repare Therapeutics Inc
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and ...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Steve Forte CPA
Employees:129
Headquarters:Montreal, Canada
Website:www.reparerx.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions